PERSPECTA

News from every angle

← Back to headlines

RFK Jr.'s Peptide Policy Could Boost Hims & Hers GLP-1 Business

RFK Jr.'s peptide policy could provide a growth opportunity for Hims & Hers as its GLP-1 business evolves, with an FDA review expected in 2026.

16 Apr, 17:44 — 16 Apr, 17:44
PostShare

Sources

Showing 1 of 1 sources
cnbcMostly Factual7d ago

RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves

Hims may have an chance to grow peptides business as a potential revenue driver, with FDA review in 2026 shaping the opportunity.

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Bukidnon Hosts Regional Innovation Exhibit

just now

Philippine DOE Considers Lifting Coal Plant Moratorium Amid Concerns

just now

Police Official Implicated as P784-M Counterfeit Cigarettes Seized in Negros Occidental

just now